Validation of the Gated Blood Pool SPECT: ERNA vs 3D Echo
Completed
Conditions studied: Congestive Heart Failure, Ventricular Function, Left
In brief
This research study is designed to evaluate the accuracy of the techniques that are used to analyze heart function. The main purpose of this study is to analyze and compare three different methods of assessment of regional and overall heart function.
Key facts
- Study ID
- NCT00576186
- Run by
- Yale University
- People needed
- 30
- Starts
- 2005-02-01
- Expected to finish
- 2015-11-01
- Last updated by the study team
- 2016-06-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All patients scheduled for routine clinically requested ERNA study for ejection fraction measurement at the Yale University Cardiovascular Nuclear Imaging Laboratory are eligible to be enrolled in the study.
You may not qualify if…
- Unstable medical condition preventing additional imaging.
- Weight greater than 300lbs, prohibiting imaging on the SPECT/CT imaging system.
- Patients with intracardiac shunts, emphysema or previously demonstrated allergies to octafluoropropane (the gas in the microbubbles), will not receive intravenous contrast during 3 DE image acquisition.
Where it is running
- Yale New Haven Hospital — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.